Parkside Financial Bank & Trust’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.3K Sell
719
-44
-6% -$1.03K ﹤0.01% 1383
2026
Q1
$14.6K Buy
763
+292
+62% +$6.45K ﹤0.01% 1443
2025
Q4
$11.4K Sell
471
-15
-3% -$392 ﹤0.01% 1525
2025
Q3
$12.4K Sell
486
-2
-0.4% -$47 ﹤0.01% 1434
2025
Q2
$10.5K Buy
488
+194
+66% +$4.37K ﹤0.01% 1468
2025
Q1
$6.72K Buy
294
+19
+7% +$500 ﹤0.01% 1551
2024
Q4
$7.14K Buy
275
+70
+34% +$1.74K ﹤0.01% 1377
2024
Q3
$5.13K Buy
205
+41
+25% +$968 ﹤0.01% 1427
2024
Q2
$3.52K Buy
164
+142
+645% +$2.76K ﹤0.01% 1445
2024
Q1
$409 Hold
22
﹤0.01% 1795
2023
Q4
$358 Sell
22
-97
-82% -$1.24K ﹤0.01% 1813
2023
Q3
$1.64K Sell
119
-19
-14% -$299 ﹤0.01% 1720
2023
Q2
$3.05K Hold
138
﹤0.01% 1550
2023
Q1
$3K Buy
138
+126
+1,050% +$2.83K ﹤0.01% 1561
2022
Q4
$218 Sell
12
-64
-84% -$1.32K ﹤0.01% 1958
2022
Q3
$2K Buy
76
+64
+533% +$1.37K ﹤0.01% 1503
2022
Q2
$0 Buy
12
+2
+20% +$29 ﹤0.01% 1822
2022
Q1
$0 Buy
+10
New +$263 ﹤0.01% 1831

Other funds holding BLFS

Parkside Financial Bank & Trust's BLFS Position: Q2 2026 in Review

Parkside Financial Bank & Trust reduced its BioLife Solutions (BLFS) stake by 5.8% in Q2 2026, selling an estimated $1.03K and leaving 719 shares worth $20.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1383.

Parkside Financial Bank & Trust first reported a position in BLFS in Q1 2022 and has held it in 18 quarters since. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Parkside Financial Bank & Trust held 719 shares of BioLife Solutions worth $20.3K as of Q2 2026.
  • Parkside Financial Bank & Trust sold 44 BioLife Solutions shares in Q2 2026, an estimated $1.03K.
  • BioLife Solutions made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #1383 holding.
  • Parkside Financial Bank & Trust first reported a position in BioLife Solutions in Q1 2022 and has held it in 18 quarters since.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.